TradingView
mrezaei
Dec 15, 2016 4:25 AM

Possible Long Opportunity 

Sarepta Therapeutics, Inc.NASDAQ

Description

NASDAQ:SRPT is already almost oversold but I think $24.2 would be a good level to buy for a long position, lets see...
More